KALV: KalVista Pharmaceuticals Inc

14.05 USD 0.23 (1.66%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de KALV de hoy ha cambiado un 1.66%. En este caso, el precio mínimo en el mercado ha alcanzado 13.68, mientras que el máximo ha alcanzado 14.34.

Siga la dinámica de la pareja de divisas KalVista Pharmaceuticals Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

KALV News

Seeking Alpha 09:02 KalVista's EKTERLY Faces Shrinking Market, Oral Competitor Threat (Downgrade) (KALV)
Investing 12:32 European regulator recommends approval of first oral HAE treatment
Investing 08:59 Kalvista Pharmaceuticals stock maintains Market Outperform rating at JMP
Investing 09:05 JMP reiterates Market Outperform rating on Kalvista stock after UK approval
Investing 20:12 UK approves first oral treatment for hereditary angioedema attacks
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Benzinga 12:14 Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple (NASDAQ:AAPL), Above Food Ingredients (NASDAQ:ABVE)
Investing 11:25 Kalvista stock maintains Buy rating at H.C. Wainwright on favorable Ekterly label
Investing 01:01 Kalvista Pharma CEO Palleiko sells $517k in shares
Investing 00:52 Kalvista Pharma chief development officer sells $474k in shares
Investing 15:15 Leerink Partners reiterates Outperform rating on Kalvista stock as Ekterly launch begins
Seeking Alpha 19:52 KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning (KALV)
Benzinga 14:03 Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)
Investing 08:53 Kalvista stock price target raised to $27 from $19 at JMP on Ekterly pricing
Investing 19:27 Kalvista stock rises as Leerink raises price target on FDA approval
Investing 18:01 Tesla, Circle Internet Surge Among Monday’s Market Cap Stock Movers
Investing 17:11 KalVista stock price target raised to $37 from $22 at BofA on Ekterly approval
Investing 14:36 Kalvista stock jumps as Stifel reiterates Buy rating on Ekterly approval
Investing 14:31 Tesla, Oracle among Monday’s market cap stock movers
Benzinga 14:05 KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
Investor's Business Daily 13:12 KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment
Investing 12:22 US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
Benzinga 11:47 Why Is KalVista Pharmaceuticals Stock Soaring On Monday? - KalVista Pharma (NASDAQ:KALV)
Investing 11:26 KalVista stock soars after FDA approves first oral HAE treatment

Rango diario

13.68 14.34

Rango anual

7.31 16.32

Cierres anteriores: 13.75
Open: 13.82

Bid: 14.05
Ask: 14.35

Low: 13.68
High: 14.34

Volumen: 1.843 K

Cambio diario: 1.66%
Cambio mensual: 24.89%

Cambio a 6 meses: 60.39%
Cambio anual: -5.32%

30 julio, miércoles